top of page
Search

FDA Requiring RFID Immunity




The FDA has recognized the AIM 7351731 RFID Immunity testing as part of 510K/PMA submissions. This standard addressed the rise in RFID tags and readers used in medical facilities for tracking pharmaceuticals and medical supplies and has the following requirements;

As an alternative to this, the FDA is accepting the IEC 60601-1-2:2020 (edition 4.1) table 11 test in lieu of AIM 7351731 to address the RFID immunity requirements. The latest edition of the IEC 60601-1-2:2020 has the following requirements;

The latest medical collateral EMC standard IEC 60601-1-2:2020is a recognized consensus standard by the FDA. For Europe, the EN version has a dop date of 2021-09-19 and a dow date of 2024-03-19 allowing for a 3 year transition time before mandatory adoption.


Recent Posts

See All

March, 2023 The Ministry of Industry and Information Technology (MIIT) of China announced on February 6, 2023 that they would be reforming the Network Access License (NAL) System. The announcement inc

bottom of page